oltipraz has been researched along with Acute Kidney Failure in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, W; Chen, W; Ding, M; Guo, H; Lin, T; Wang, T; Wei, H; Yu, H; Zhang, C; Zhao, S; Zhao, X | 1 |
| Abdo, S; Chan, JS; Chenier, I; Filep, JG; Ghosh, A; Ingelfinger, JR; Lo, CS; Otoukesh, A; Shi, Y; Zhang, SL | 1 |
| Bae, SK; Kim, JW; Kim, SG; Kim, YH; Lee, MG; Lee, SJ | 1 |
3 other study(ies) available for oltipraz and Acute Kidney Failure
| Article | Year |
|---|---|
Size and temporal-dependent efficacy of oltipraz-loaded PLGA nanoparticles for treatment of acute kidney injury and fibrosis.
Topics: Acute Kidney Injury; Animals; Antioxidants; Fibrosis; Mice; Nanoparticles; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrazines; Reperfusion Injury; Thiones; Thiophenes; Time Factors; Tissue Distribution; Treatment Outcome | 2019 |
Catalase overexpression prevents nuclear factor erythroid 2-related factor 2 stimulation of renal angiotensinogen gene expression, hypertension, and kidney injury in diabetic mice.
Topics: Acute Kidney Injury; Angiotensinogen; Animals; Blood Glucose; Catalase; Diabetes Mellitus, Experimental; Gene Expression; Hypertension; Kidney Tubules, Proximal; Mice; Mice, Transgenic; NF-E2-Related Factor 2; NF-kappa B; Pyrazines; Reverse Transcriptase Inhibitors; Signal Transduction; Thiones; Thiophenes | 2014 |
Effects of acute renal failure on the pharmacokinetics of oltipraz in rats.
Topics: Acute Kidney Injury; Animals; Male; Pyrazines; Rats; Rats, Sprague-Dawley; Thiones; Thiophenes | 2004 |